UTI UNIVERSAL TECHNICAL INSTITUTE INC
NYSE · SEC CIK 1261654 · EDGAR
- Bought, last 12 months
- $31.13M 7 purchases by 2 insiders
- Sold, last 12 months
- $135.13M 13 sales by 11 insiders
- Filings on record
- 264 since 2021-09-16, latest 2026-09-23 20:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Coliseum Capital Management, LLC | Dir | $30.81M | $124.20M |
| Grant Jerome Alan | CEO, Dir | — | $6.01M |
| Smith Sherrell | EVP, Chief Academic Off | — | $1.95M |
| Kevane Christopher E. | EVP, CLO | — | $888.2K |
| Hitchcock Todd A | EVP, COO | — | $615.9K |
| SRERE LINDA J | Dir | — | $548.8K |
| Okinaka Shannon Lei | Dir | — | $347.4K |
| DEVINCENZI ROBERT THOMAS | Dir | $315.0K | — |
| Brochick George W. | Dir | — | $183.0K |
| Prehn Kevin | Concorde Division Pres | — | $181.8K |
Transactions 327
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-27 | 2025-02-26 | UTI | Brochick George W. | Dir | S - Sale | $27.59 | -8,000 | 34.9K | -19% | -$220.7K | |
| I | 2025-02-11 | 2025-02-10 | UTI | Shackelton Christopher S | Dir, 10% | S - Sale | $28.20 | -704.9K | 6.15M | -10% | -$19.88M |
| 2025-01-21 | 2025-01-16 | UTI | Frank Carolyn Ann | See Remarks | F - Tax | $26.00 | -2,162 | 25.7K | -8% | -$56.2K | |
| 2024-12-19 | 2024-12-18 | UTI | LENNOX WILLIAM J JR | Dir | G - Gift | $0.00 | -3,800 | 115.3K | -3% | $0 | |
| 2024-12-17 | 2024-12-17 | UTI | Kline Christine | CAO, Interim CFO | F - Tax | $25.77 | -626 | 40.7K | -2% | -$16.1K | |
| 2024-12-17 | 2024-12-13 | UTI | Kline Christine | CAO, Interim CFO | A - Grant | $0.00 | +2,246 | 41.3K | +6% | $0 | |
| 2024-12-17 | 2024-12-17 | UTI | Kevane Christopher E. | EVP, CLO | F - Tax | $25.77 | -4,759 | 103.1K | -4% | -$122.6K | |
| 2024-12-17 | 2024-12-13 | UTI | Kevane Christopher E. | EVP, CLO | A - Grant | $0.00 | +13.4K | 107.8K | +14% | $0 | |
| 2024-12-17 | 2024-12-13 | UTI | Hitchcock Todd A | EVP Chief Strategy, Transform | A - Grant | $0.00 | +13.6K | 112.5K | +14% | $0 | |
| 2024-12-17 | 2024-12-17 | UTI | Hitchcock Todd A | EVP Chief Strategy, Transform | F - Tax | $25.77 | -4,440 | 108.0K | -4% | -$114.4K | |
| 2024-12-17 | 2024-12-17 | UTI | Smith Sherrell | EVP, Chief Academic Off | F - Tax | $25.77 | -6,314 | 264.1K | -2% | -$162.7K | |
| 2024-12-17 | 2024-12-13 | UTI | Smith Sherrell | EVP, Chief Academic Off | A - Grant | $0.00 | +15.2K | 270.4K | +6% | $0 | |
| 2024-12-17 | 2024-12-17 | UTI | Grant Jerome Alan | CEO, Dir | F - Tax | $25.77 | -22.8K | 401.1K | -5% | -$587.2K | |
| 2024-12-17 | 2024-12-13 | UTI | Grant Jerome Alan | CEO, Dir | A - Grant | $0.00 | +55.1K | 423.9K | +15% | $0 | |
| 2024-12-17 | 2024-12-13 | UTI | Smith Lori B | SVP CIO | A - Grant | $0.00 | +9,725 | 93.9K | +12% | $0 | |
| 2024-12-17 | 2024-12-17 | UTI | Smith Lori B | SVP CIO | F - Tax | $25.77 | -2,709 | 91.2K | -3% | -$69.8K | |
| 2024-12-16 | 2024-12-12 | UTI | Grant Jerome Alan | CEO, Dir | A - Grant | — | +67.3K | 368.8K | +22% | — | |
| 2024-12-11 | 2024-12-10 | UTI | Grant Jerome Alan | CEO, Dir | F - Tax | $25.62 | -42.3K | 301.5K | -12% | -$1.08M | |
| 2024-12-10 | 2024-12-08 | UTI | Kline Christine | CAO, Interim CFO | A - Grant | — | +23.4K | 40.2K | +139% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Kline Christine | CAO, Interim CFO | F - Tax | $25.62 | -1,131 | 39.0K | -3% | -$29.0K | |
| 2024-12-10 | 2024-12-08 | UTI | Kevane Christopher E. | EVP, CLO | F - Tax | $25.62 | -5,809 | 94.5K | -6% | -$148.8K | |
| 2024-12-10 | 2024-12-08 | UTI | Kevane Christopher E. | EVP, CLO | A - Grant | — | +11.7K | 100.3K | +13% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Smith Sherrell | EVP, Chief Academic Off | F - Tax | $25.62 | -10.1K | 255.3K | -4% | -$258.5K | |
| 2024-12-10 | 2024-12-08 | UTI | Smith Sherrell | EVP, Chief Academic Off | A - Grant | — | +9,355 | 265.4K | +4% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Frank Carolyn Ann | See Remarks | A - Grant | — | +8,185 | 27.8K | +42% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Smith Lori B | SVP CIO | F - Tax | $25.62 | -3,966 | 84.2K | -4% | -$101.6K | |
| 2024-12-10 | 2024-12-08 | UTI | Smith Lori B | SVP CIO | A - Grant | — | +5,847 | 88.2K | +7% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Prehn Kevin | Concorde Division Pres | A - Grant | — | +7,718 | 10.8K | +251% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Prehn Kevin | Concorde Division Pres | F - Tax | $25.62 | -2,108 | 8,680 | -20% | -$54.0K | |
| 2024-12-10 | 2024-12-08 | UTI | Hitchcock Todd A | EVP Chief Strategy, Transform | F - Tax | $25.62 | -5,164 | 98.8K | -5% | -$132.3K | |
| 2024-12-10 | 2024-12-08 | UTI | Hitchcock Todd A | EVP Chief Strategy, Transform | A - Grant | — | +18.7K | 104.0K | +22% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Lorenz Tracy Kay | UTI Division Pres | A - Grant | — | +9,004 | 43.7K | +26% | — | |
| 2024-12-10 | 2024-12-08 | UTI | Lorenz Tracy Kay | UTI Division Pres | F - Tax | $25.62 | -1,390 | 42.3K | -3% | -$35.6K | |
| I | 2024-12-03 | 2024-12-02 | UTI | Gray Adam | Dir, 10% | S - Sale | $25.10 | -2.48M | 6.85M | -27% | -$62.34M |
| D | 2024-11-29 | 2024-11-27 | UTI | TRAMMELL KENNETH R | Dir | S - Sale+OE | $25.92 | -30.0K | 128.2K | -19% | -$777.6K |
| D | 2024-11-29 | 2024-11-27 | UTI | TRAMMELL KENNETH R | Dir | M - OptEx | $3.14 | +30.0K | 158.2K | +23% | +$94.2K |
| D | 2024-11-29 | 2024-11-26 | UTI | SRERE LINDA J | Dir | S - Sale+OE | $25.53 | -30.0K | 134.7K | -18% | -$765.9K |
| D | 2024-11-29 | 2024-11-26 | UTI | SRERE LINDA J | Dir | M - OptEx | $3.14 | +30.0K | 164.7K | +22% | +$94.2K |
| DM | 2024-11-27 | 2024-11-25 | UTI | DEVINCENZI ROBERT THOMAS | Dir | S - Sale+OE | $25.45 | -150.0K | 128.5K | -54% | -$3.82M |
| D | 2024-11-27 | 2024-11-25 | UTI | DEVINCENZI ROBERT THOMAS | Dir | M - OptEx | $3.14 | +150.0K | 272.5K | +122% | +$471.0K |
| 2024-08-23 | 2024-08-23 | UTI | Grant Jerome Alan | CEO, Dir | S - Sale | $17.53 | -68.0K | 136.4K | -33% | -$1.19M | |
| D | 2024-05-29 | 2024-05-24 | UTI | Lorenz Tracy Kay | UTI Division Pres | F - Tax | $15.32 | -2,217 | 3,132 | -41% | -$34.0K |
| D | 2024-05-29 | 2024-05-24 | UTI | Lorenz Tracy Kay | UTI Division Pres | M - OptEx | $0.00 | +5,349 | 5,349 | New | $0 |
| 2024-05-29 | 2024-05-24 | UTI | Sanchez Loretta Lydia | Dir | S - Sale | $15.22 | -6,288 | 13.7K | -31% | -$95.7K | |
| 2024-03-28 | 2024-03-26 | UTI | Sanchez Loretta Lydia | Dir | S - Sale | $15.07 | -8,719 | 20.0K | -30% | -$131.4K | |
| 2024-03-01 | 2024-02-28 | UTI | DEVINCENZI ROBERT THOMAS | Dir | A - Grant | $0.00 | +6,789 | 122.5K | +6% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | TRAMMELL KENNETH R | Dir | A - Grant | $0.00 | +6,789 | 128.2K | +6% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | SRERE LINDA J | Dir | A - Grant | $0.00 | +6,789 | 134.7K | +5% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | Sanchez Loretta Lydia | Dir | A - Grant | $0.00 | +6,789 | 28.7K | +31% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | Blaszkiewicz David | Dir | A - Grant | $0.00 | +6,789 | 119.7K | +6% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | Okinaka Shannon Lei | Dir | A - Grant | $0.00 | +6,789 | 21.9K | +45% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | LENNOX WILLIAM J JR | Dir | A - Grant | $0.00 | +6,789 | 119.1K | +6% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | Slubowski Michael A. | Dir | A - Grant | $0.00 | +6,789 | 12.8K | +113% | $0 | |
| 2024-03-01 | 2024-02-28 | UTI | Brochick George W. | Dir | A - Grant | $0.00 | +6,789 | 42.9K | +19% | $0 | |
| DA | 2024-02-16 | 2024-02-15 | UTI | Prehn Kevin | Concorde Division Pres | M - OptEx | $11.88 | +1,160 | 1,160 | New | +$13.8K |
| DA | 2024-02-16 | 2024-02-15 | UTI | Prehn Kevin | Concorde Division Pres | F - Tax | $11.88 | -412 | 748 | -36% | -$4,895 |
| I | 2024-02-16 | 2024-02-15 | UTI | Shackelton Christopher S | Dir, 10% | S - Sale | $15.05 | -3.96M | 9.33M | -30% | -$59.54M |
| DI | 2023-12-19 | 2023-12-18 | UTI | Shackelton Christopher S | Dir, 10% | C - Cnv Deriv | — | +12.36M | 13.29M | +1,331% | — |
| D | 2023-12-18 | 2023-12-14 | UTI | Kevane Christopher E. | SVP CLO | M - OptEx | $0.00 | +13.2K | 51.1K | +35% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Kevane Christopher E. | SVP CLO | F - Tax | $10.94 | -3,664 | 47.4K | -7% | -$40.1K |
| D | 2023-12-18 | 2023-12-14 | UTI | Smith Lori B | SVP CIO | M - OptEx | $0.00 | +8,419 | 57.7K | +17% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Smith Lori B | SVP CIO | F - Tax | $10.94 | -2,345 | 55.4K | -4% | -$25.7K |
| D | 2023-12-18 | 2023-12-14 | UTI | Smith Sherrell | EVP, Campus Ops, Services | M - OptEx | $0.00 | +13.7K | 214.9K | +7% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Smith Sherrell | EVP, Campus Ops, Services | F - Tax | $10.94 | -5,686 | 209.2K | -3% | -$62.2K |
| D | 2023-12-18 | 2023-12-14 | UTI | Kline Christine | CAO | F - Tax | $10.94 | -587 | 8,172 | -7% | -$6,422 |
| D | 2023-12-18 | 2023-12-14 | UTI | Kline Christine | CAO | M - OptEx | $0.00 | +2,105 | 8,759 | +32% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Anderson Troy R | EVP, CFO | S - Sale+OE | $10.94 | -7,173 | 87.4K | -8% | -$78.5K |
| D | 2023-12-18 | 2023-12-14 | UTI | Anderson Troy R | EVP, CFO | M - OptEx | $0.00 | +17.6K | 94.6K | +23% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Grant Jerome Alan | CEO, Dir | F - Tax | $10.94 | -23.9K | 204.4K | -10% | -$261.8K |
| D | 2023-12-18 | 2023-12-14 | UTI | Grant Jerome Alan | CEO, Dir | M - OptEx | $0.00 | +57.9K | 228.4K | +34% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Hitchcock Todd A | SVP Chief Strategy, Transform | M - OptEx | $0.00 | +8,419 | 45.6K | +23% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Hitchcock Todd A | SVP Chief Strategy, Transform | F - Tax | $10.94 | -2,051 | 43.5K | -4% | -$22.4K |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Kevane Christopher E. | SVP CLO | M - OptEx | — | +22.2K | 28.4K | +358% | — |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Kevane Christopher E. | SVP CLO | F - Tax | $11.88 | -6,179 | 26.6K | -19% | -$73.4K |
| DMA | 2023-12-13 | 2023-12-08+ | UTI | Smith Lori B | SVP CIO | M - OptEx | — | +15.7K | 47.7K | +49% | — |
| DMA | 2023-12-13 | 2023-12-08+ | UTI | Smith Lori B | SVP CIO | F - Tax | $11.88 | -4,379 | 49.3K | -8% | -$52.0K |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Kline Christine | CAO | F - Tax | $11.88 | -1,014 | 5,816 | -15% | -$12.0K |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Kline Christine | CAO | M - OptEx | — | +3,634 | 6,978 | +109% | — |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Hitchcock Todd A | SVP Chief Strategy, Transform | F - Tax | $11.88 | -4,990 | 37.2K | -12% | -$59.3K |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Hitchcock Todd A | SVP Chief Strategy, Transform | M - OptEx | — | +20.5K | 38.4K | +114% | — |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Smith Lori B | SVP CIO | F - Tax | $11.88 | -4,379 | 49.3K | -8% | -$52.0K |
| DM | 2023-12-13 | 2023-12-08+ | UTI | Smith Lori B | SVP CIO | M - OptEx | — | +15.7K | 42.7K | +58% | — |
| D | 2023-12-13 | 2023-12-08 | UTI | Prehn Kevin | Concorde Division Pres | M - OptEx | $0.00 | +1,160 | 1,160 | New | $0 |
| D | 2023-12-13 | 2023-12-08 | UTI | Prehn Kevin | Concorde Division Pres | F - Tax | $11.88 | -315 | 845 | -27% | -$3,742 |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Smith Sherrell | EVP, Campus Ops, Services | F - Tax | $11.88 | -10.8K | 196.7K | -5% | -$128.9K |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Smith Sherrell | EVP, Campus Ops, Services | M - OptEx | — | +26.0K | 204.5K | +15% | — |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Grant Jerome Alan | CEO, Dir | M - OptEx | $0.00 | +105.1K | 171.0K | +159% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Grant Jerome Alan | CEO, Dir | F - Tax | $11.88 | -43.4K | 151.8K | -22% | -$516.1K |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Anderson Troy R | EVP, CFO | M - OptEx | $0.00 | +43.1K | 58.8K | +274% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | UTI | Anderson Troy R | EVP, CFO | F - Tax | $11.88 | -11.8K | 69.5K | -15% | -$140.1K |
| 2023-10-02 | 2023-09-28 | UTI | Sanchez Loretta Lydia | Dir | S - Sale | $8.52 | -7,599 | 21.9K | -26% | -$64.7K | |
| D | 2023-09-19 | 2023-09-15 | UTI | Fesperman Bart | SVP Chief Commercial Off | M - OptEx | $0.00 | +3,778 | 20.1K | +23% | $0 |
| D | 2023-09-19 | 2023-09-15 | UTI | Fesperman Bart | SVP Chief Commercial Off | F - Tax | $8.47 | -996 | 19.1K | -5% | -$8,436 |
| MI | 2023-06-23 | 2023-06-21+ | UTI | Shackelton Christopher S | Dir, 10% | P - Purchase | $6.67 | +307.6K | 647.6K | +90% | +$2.05M |
| MI | 2023-03-30 | 2023-03-28+ | UTI | Gray Adam | Dir, 10% | P - Purchase | $6.93 | +149.2K | 478.4K | +45% | +$1.03M |
| D | 2023-03-06 | 2023-03-02 | UTI | Kevane Christopher E. | SVP CLO | M - OptEx | $0.00 | +3,326 | 23.0K | +17% | $0 |
| D | 2023-03-06 | 2023-03-02 | UTI | Kevane Christopher E. | SVP CLO | F - Tax | $0.00 | -1,103 | 21.9K | -5% | $0 |
| 2023-03-02 | 2023-03-01 | UTI | Slubowski Michael A. | Dir | A - Grant | $7.32 | +6,008 | 6,008 | New | +$44.0K | |
| 2023-02-23 | 2023-02-22 | UTI | Brochick George W. | Dir | A - Grant | $0.00 | +9,895 | 36.1K | +38% | $0 | |
| 2023-02-23 | 2023-02-22 | UTI | Sanchez Loretta Lydia | Dir | A - Grant | $0.00 | +9,895 | 29.5K | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations